» Articles » PMID: 444788

A New Depression Scale Designed to Be Sensitive to Change

Overview
Journal Br J Psychiatry
Specialty Psychiatry
Date 1979 Apr 1
PMID 444788
Citations 3726
Authors
Affiliations
Soon will be listed here.
Abstract

The construction of a depression rating scale designed to be particularly sensitive to treatment effects is described. Ratings of 54 English and 52 Swedish patients on a 65 item comprehensive psychopathology scale were used to identify the 17 most commonly occurring symptoms in primary depressive illness in the combined sample. Ratings on these 17 items for 64 patients participating in studies of four different antidepressant drugs were used to create a depression scale consisting of the 10 items which showed the largest changes with treatment and the highest correlation to overall change. The inner-rater reliability of the new depression scale was high. Scores on the scale correlated significantly with scores on a standard rating scale for depression, the Hamilton Rating Scale (HRS), indicating its validity as a general severity estimate. Its capacity to differentiate between responders and non-responders to antidepressant treatment was better than the HRS, indicating greater sensitivity to change. The practical and ethical implications in terms of smaller sample sizes in clinical trials are discussed.

Citing Articles

Brief, pragmatic measure of emotion dysregulation in young people - a preliminary validation of the BER-5.

Dibaj I, Neupane S, Mehlum L Borderline Personal Disord Emot Dysregul. 2025; 12(1):8.

PMID: 40083026 PMC: 11905671. DOI: 10.1186/s40479-025-00285-4.


Neuroimaging changes in major depression with brief computer-assisted cognitive behavioral therapy compared to waitlist.

Sheline Y, Thase M, Hembree E, Balderston N, Nitchie F, Batzdorf A Mol Psychiatry. 2025; .

PMID: 40069356 DOI: 10.1038/s41380-025-02945-x.


Efficacy and safety of GLP-1 agonists in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials.

Messak M, Abdelmageed A, Senbel A, Khattab Y, Mandour Y, Shaker O Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40067438 DOI: 10.1007/s00210-025-03932-3.


Investigating the impact of electroconvulsive therapy on brain networks and sleep: an observational study protocol.

Kafashan M, Lebovitz L, Greenspan R, Zhao S, Kim T, Husain M BMJ Open. 2025; 15(3):e098859.

PMID: 40054874 PMC: 11891538. DOI: 10.1136/bmjopen-2025-098859.


Body mass index is associated with the antidepressant effects of intravenous ketamine in patients with depression.

Tan J, Gu L, Zhou Y, Wang C, Lan X, Zheng W Front Psychiatry. 2025; 16:1498952.

PMID: 40041696 PMC: 11876371. DOI: 10.3389/fpsyt.2025.1498952.